ClinicalTrials.gg
Sign In

Retinal Diseases clinical trials

The registry lists 333 studies for Retinal Diseases across more than 10 countries. 60 are recruiting or about to start. 99 of them are mainly about Retinal Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 26 narrower conditions too, such as Macular Degeneration: 4,401 studies, 696 open.

Get an email when these change. Save the Retinal Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
171
Recruiting
44
Terminated
38
Status unknown
35
Active, not recruiting
23
Not yet recruiting
11

Phase

Phase 2
73
Phase 1
53
Phase 3
39
Phase 4
15
Early Phase 1
3

Where

United States
162
United Kingdom
33
France
32
China
29
Germany
27
Canada
20

Who runs them

National Eye Institute (NEI) (19) · Novartis Pharmaceuticals (8) · Duke University (7) · Laboratoires Thea (7) · Optos, PLC (7) · Kodiak Sciences Inc (7) · Bayer (5) · Gyroscope Therapeutics Limited (5)

What is being tested here

Drugs under test in Retinal Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Sepofarsen134
IRX-101112
Minocycline112
Montelukast101
Semaglutide111
Dapagliflozin101
Ranibizumab0618
Tarcocimab tedromer066
Aflibercept024
Brolucizumab034

Drug classes tested here Angiogenesis inhibitors 23 · Corticosteroids 4

Coming up

8phase 3 studies under way
20studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 44 Retinal Diseases studies recruiting now, 30 (68%) set no upper age limit and 4 (9%) stop at 75 or younger. 16 (36%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 19 (43%) take healthy volunteers.

Recruiting studies that take each age, of 44
AgeWomenMen
1014 (32%)14 (32%)
1833 (75%)33 (75%)
3035 (80%)35 (80%)
4038 (86%)38 (86%)
5042 (95%)42 (95%)
6541 (93%)41 (93%)
7541 (93%)41 (93%)
8539 (89%)39 (89%)

Across all 333 studies, recruiting or not: 16% stop at 75 or younger and 12% at 65; 28% take children; <1% are for women only and 1% for men only; 29% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Retinal Diseases studies take

Of 18 phase 2 interventional studies under Retinal Diseases, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 224 mo19–38 · 18 studies——
Interventional, no phase18 mo8–66 · 42 studies——
Observational53 mo19–… · 53 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 333. Browse all 333 → or search them.